Latest topics page 10
Topics ordered by most recent activity across all 71 subcategories.
1,535 topics · page 10 of 52
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Risk-of-bias tools and the judgement they conceal — does this still hold?
Risk-of-bias tools and the judgement they conceal — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Comparing SURPASS-2 ( N Engl J Med , 2021)…
|
+26 | 30 | 5.8k | 23h |
|
[2026 update] Comparing prices across jurisdictions without misleading yourself
On the subject in the title: Comparing prices across jurisdictions without misleading yourself Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category…
|
2 | 809 | 23h | |
|
Why a pen's dose steps are fixed and what that costs you
The question in the title: Why a pen's dose steps are fixed and what that costs you I will give what I have already checked below so nobody repeats it. I have read the maintained page on this and I still have…
|
4 | 2.5k | 23h | |
|
What "marked as solution" means and who gets to mark it
Asking directly, because I could not find a straight answer: What "marked as solution" means and who gets to mark it Question in the title. Context below, and I have tried to include the things people here…
|
2 | 290 | 1d | |
|
Tracking semaglutide's approved indications across jurisdictions, dated
Tracking semaglutide's approved indications across jurisdictions, dated Writing it up because I had to work it out twice and would rather nobody else did. I have seen SURMOUNT-OSA ( N Engl J Med , 2024) cited…
|
+15 | 19 | 2.8k | 1d |
|
Historical amylin analogues and what happened to them
Posting this under the heading it deserves: Historical amylin analogues and what happened to them Everything below is what sits behind that. I have seen SURPASS-2 ( N Engl J Med , 2021) cited in support of a…
|
+29 | 36 | 31k | 1d |
|
What steady state means for the decision to escalate
What steady state means for the decision to escalate — that is the question, and I have not found it answered plainly anywhere I have looked. Reporting something rather than asking about it, in case the…
|
+31 | 35 | 2k | 1d |
|
Pooling trials with different estimands
On the subject in the title: Pooling trials with different estimands Working notes rather than a conclusion. Comparing SELECT ( N Engl J Med , 2023) with SURMOUNT-1 ( N Engl J Med , 2022) and finding the…
|
+120 | 132 | 2.3k | 1d |
|
A structured critique template this community uses
A structured critique template this community uses — setting out what I have, and where I think it stops being reliable. Comparing SURMOUNT-2 ( Lancet , 2023) with SURPASS-4 ( Lancet , 2021) and finding the…
|
2 | 18k | 1d | |
|
Selection into a registry and what it does to the estimate — a second dataset
Posting this under the heading it deserves: Selection into a registry and what it does to the estimate — a second dataset Everything below is what sits behind that. Session topic: SURMOUNT-4 ( JAMA , 2024).…
|
+28 | 32 | 1.3k | 1d |
|
Peer-to-peer review: what actually happens on the call
On the subject in the title: Peer-to-peer review: what actually happens on the call Working notes rather than a conclusion. Documenting an access outcome, dated, because everything in this category expires.…
|
2 | 1.2k | 1d | |
|
Micro-titration: a disputed topic, argued properly — one year on
Posting this under the heading it deserves: Micro-titration: a disputed topic, argued properly — one year on Everything below is what sits behind that. A question about technique rather than about dose. I…
|
+63 | 68 | 35k | 1d |
|
Completing a dose with a second syringe, and the dead-volume arithmetic
Posting this under the heading it deserves: Completing a dose with a second syringe, and the dead-volume arithmetic Everything below is what sits behind that. I have read the maintained page on this and I…
|
+65 | 76 | 7.4k | 1d |
|
Travelling with an injectable: documentation and practicalities
Posting this under the heading it deserves: Travelling with an injectable: documentation and practicalities Everything below is what sits behind that. Documenting an access outcome, dated, because everything…
|
+37 | 42 | 2.1k | 1d |
|
Reading U-100 graduations, with a conversion table
Posting this under the heading it deserves: Reading U-100 graduations, with a conversion table Everything below is what sits behind that. Practical question with the units stated, because I have seen how…
|
+35 | 41 | 2k | 1d |
|
Tesamorelin has an approved indication — what that changes about the evidence
Tesamorelin has an approved indication — what that changes about the evidence — setting out what I have, and where I think it stops being reliable. Comparing STEP 4 ( JAMA , 2021) with SURMOUNT-1 ( N Engl J…
|
+23 | 27 | 3.4k | 1d |
|
Coming back to: Why I now write the concentration on the vial in marker
The question in the title: Why I now write the concentration on the vial in marker I will give what I have already checked below so nobody repeats it. Practical question with the units stated, because I have…
|
+8 | 12 | 4.3k | 1d |
|
Revisiting: Taste changes and food aversion, reported and discussed
Revisiting: Taste changes and food aversion, reported and discussed Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page on this and I still have…
|
+20 | 25 | 4.3k | 1d |
|
Subgroup analyses: pre-specified versus discovered
Subgroup analyses: pre-specified versus discovered — setting out what I have, and where I think it stops being reliable. Comparing SURMOUNT-2 ( Lancet , 2023) with SURPASS-4 ( Lancet , 2021) and finding the…
|
2 | 27k | 1d | |
|
[2026 update] Journal club: what we got wrong in an earlier session
Journal club: what we got wrong in an earlier session — setting out what I have, and where I think it stops being reliable. I have seen STEP 4 ( JAMA , 2021) cited in support of a claim I do not think it…
|
+5 | 9 | 4.2k | 1d |
|
Type 2 diabetes and the largest part of the evidence base — does this still hold?
Type 2 diabetes and the largest part of the evidence base — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Asking about a population rather…
|
+17 | 22 | 4.5k | 1d |
|
What changed in 2026, by region — does this still hold?
What changed in 2026, by region — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Documenting an access outcome, dated, because everything in…
|
+20 | 25 | 50k | 1d |
|
Follow-up: Signs of dehydration worth acting on
Posting this under the heading it deserves: Signs of dehydration worth acting on Everything below is what sits behind that. General question, not a request for advice about my own care — I know the difference…
|
+35 | 39 | 9.8k | 1d |
|
Asking a follow-up: new topic or new reply?
Asking a follow-up: new topic or new reply? — that is the question, and I have not found it answered plainly anywhere I have looked. Question in the title. Context below, and I have tried to include the…
|
+68 | 73 | 40k | 1d |
|
BPC-157: what the rodent literature actually shows, and what it does not — does this still hold?
The question in the title: BPC-157: what the rodent literature actually shows, and what it does not — does this still hold? I will give what I have already checked below so nobody repeats it. I have seen…
|
+6 | 10 | 3.1k | 1d |
|
Coming back to: Where the four-week escalation interval comes from, and what it is not
Posting this under the heading it deserves: Where the four-week escalation interval comes from, and what it is not Everything below is what sits behind that. I have read the maintained page on this and I…
|
+44 | 48 | 11k | 1d |
|
How much of the diluent volume the powder itself displaces
Asking directly, because I could not find a straight answer: How much of the diluent volume the powder itself displaces Practical question with the units stated, because I have seen how quickly these go wrong…
|
2 | 1.8k | 1d | |
|
Coming back to: Storing in the door of the fridge is worse than you think
On the subject in the title: Storing in the door of the fridge is worse than you think Working notes rather than a conclusion. I have read the maintained page on this and I still have a gap, so I am asking…
|
+2 | 6 | 2.1k | 1d |
|
Hair shedding at month three: mechanism and time course — the long version
Hair shedding at month three: mechanism and time course — the long version Writing it up because I had to work it out twice and would rather nobody else did. Reporting something rather than asking about it,…
|
+50 | 54 | 50k | 1d |
|
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs matter
Delayed gastric emptying and oral medication absorption: which drugs matter Writing it up because I had to work it out twice and would rather nobody else did. I have read the maintained page on this and I…
|
+63 | 74 | 11k | 1d |